MedPath

Rectal Evacuation Disorders and Straining-associated Symptoms in Bleeding Hemorrhoids

Not Applicable
Not yet recruiting
Conditions
Bleeding Hemorrhoids
Rectal Evacuation Disorders
Registration Number
NCT07161765
Lead Sponsor
University of Michigan
Brief Summary

This study aims to understand the mechanisms of straining on anorectal testing, to better help people receive more effective treatment advice. The study also aims to understand how point-of-care anorectal testing with an FDA-cleared device called Rectal Expulsion Device (RED) helps to identify people that might benefit from specific treatments that target pelvic floor muscle problems that lead to straining and hemorrhoids.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Participants had a colonoscopy within the last 12 months for rectal bleeding (with no cause of bleeding found other than hemorrhoids).
  • Participants provider placed an order for anorectal manometry to the University of Michigan
Exclusion Criteria
  • Anal fissure
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Intra-class correlation (ICC) between overall Patient Assessment of Constipation Symptom Score (PAC-SYM) and Hemorrhoid Disease Symptom Score (HDSS) sum scoresDay 1 (standard of care clinic visit)

The PAC-SYM survey has 12 questions in which participants select from Absent (0)-Very severe (4) There is a range of scores from 0-48 with a higher score indicating more severe symptoms.

The HDSS survey has 5 questions in which participants select from Never (0)- Every day (always) (4).

There is a range of scores from 0-20 with a higher score indicating more severe symptoms.

ICC will be assessed between overall PAC-SYM and Hemorrhoid Disease Symptom Score (HDSS) sum scores, with a value of \>0.70 considered acceptable. A sample size of 100 patients is typical to achieve a minimum acceptable ICC of 0.70 with a confidence interval of 0.10.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of MIchigan

🇺🇸

Ann Arbor, Michigan, United States

University of MIchigan
🇺🇸Ann Arbor, Michigan, United States
Brenda Ayala
Contact
734-936-4780
beayala@umich.edu
Eric Shah, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.